0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

Insulin Therapy for the Management of Diabetic Ketoacidosis Time for a Paradigm Shift?

Andrea Granados, MD1; Joyce M. Lee, MD, MPH1,2
[+] Author Affiliations
1Division of Pediatric Endocrinology, University of Michigan, Ann Arbor
2Child Health Evaluation and Research Unit, Division of General Pediatrics, University of Michigan, Ann Arbor
JAMA Pediatr. 2014;168(11):990-991. doi:10.1001/jamapediatrics.2014.1635.
Text Size: A A A
Published online

Extract

Diabetic ketoacidosis (DKA) and cerebral edema are major causes of morbidity and mortality in children with diabetes mellitus.1,2 Despite greater awareness and reports of earlier detection, approximately one-third of US children with new-onset diabetes at the time of diagnosis present with DKA,3 which is defined by the presence of hyperglycemia (blood glucose [BG] level >200 mg/dL [to convert to millimoles per liter, multiply by 0.0555]), a venous pH less than 7.3 or a bicarbonate level less than 15 mEq/L (to convert to millimoles per liter, multiply by 1), and the presence of ketonemia or ketonuria.4 Initial therapy consists of fluid resuscitation and initiation of an insulin drip; however, there is longstanding controversy regarding the optimal insulin-starting dose for the management of DKA in the pediatric population.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

1,373 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Diabetes, Foot Ulcer

Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 3rd ed
Clarifying Your Question

brightcove.createExperiences();